ReviewCurrent topics in medicinal chemistry2026
Barrier Tissue-Resident Macrophages: Natural Compounds as Modulators in Immune Function and Disease.
Review in Current topics in medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Therapies Applied to Biological Barriers: From Overcoming to Tissue Regeneration.Current topics in medicinal chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Tissue-Resident Macrophages (TRMs) are essential cells of the immune system, strategically located in barrier tissues such as the skin, lungs, and intestines. They can originate from progenitor cells in the yolk sac and fetal liver, developing distinct features that enable them to respond effectively to local challenges and maintain tissue homeostasis. The functional plasticity of TRMs allows them to adapt to diverse microenvironments, facilitating their roles in tissue repair, inflammation, and immune surveillance. Recent studies have highlighted the potential of Natural Compounds (NCs) to modulate macrophage function, offering promising therapeutic strategies for managing inflammatory diseases. These compounds have been shown to enhance or suppress specific macrophage activities, influencing immune responses and promoting healing processes. This review highlights the importance of understanding TRMs and the role of natural compounds in modulating TRM activation and function. Deciphering the potential of NCs in macrophages may shed light on the development of innovative treatments for various immune-related diseases.
Indexed as
Identifiers
40685731What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.